2022 Q1 Form 10-Q Financial Statement

#000141057822001799 Filed on May 20, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $7.000K $190.0K $39.00K
YoY Change -82.05%
Gross Profit $8.178M $14.44M $3.390M
YoY Change 141.24%
Gross Profit Margin
Selling, General & Admin $8.856M $21.26M $3.732M
YoY Change 137.3%
% of Gross Profit 108.29% 147.29% 110.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.796M $507.0K $63.00K
YoY Change 4338.1%
% of Gross Profit 34.19% 3.51% 1.86%
Operating Expenses $1.825M $1.282M $209.9K
YoY Change 769.32%
Operating Profit -$1.825M $13.15M -$209.9K
YoY Change 769.32%
Interest Expense $717.9K $3.792M $4.852M
YoY Change -85.2%
% of Operating Profit 28.83%
Other Income/Expense, Net $717.9K $0.00 $4.852M
YoY Change -85.2%
Pretax Income -$1.107M $2.510M $4.642M
YoY Change -123.85%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$1.107M $2.510M $4.642M
YoY Change -123.85%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$50.93K $85.38K $181.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.06K $177.4K $806.1K
YoY Change -95.15%
Cash & Equivalents $39.06K $177.4K $806.1K
Short-Term Investments
Other Short-Term Assets $0.00 $8.610K $148.8K
YoY Change -100.0%
Inventory
Prepaid Expenses $8.611K
Receivables $4.153M
Other Receivables $0.00
Total Short-Term Assets $39.06K $19.04M $954.9K
YoY Change -95.91% 1567.22%
LONG-TERM ASSETS
Property, Plant & Equipment $942.0K $750.0K
YoY Change
Goodwill
YoY Change
Intangibles $84.22M
YoY Change
Long-Term Investments $121.4M $0.00 $230.0M
YoY Change -47.24%
Other Assets $0.00
YoY Change
Total Long-Term Assets $121.4M $84.97M $230.0M
YoY Change -47.24% -63.06%
TOTAL ASSETS
Total Short-Term Assets $39.06K $19.04M $954.9K
Total Long-Term Assets $121.4M $84.97M $230.0M
Total Assets $121.4M $104.0M $231.0M
YoY Change -47.44% -55.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.139M $4.609M
YoY Change
Accrued Expenses $5.716M $3.985M $1.179M
YoY Change 384.99% 242.49%
Deferred Revenue
YoY Change
Short-Term Debt $750.0K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.466M $54.06M $1.179M
YoY Change 448.63% 4524.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.73M $14.44M $16.57M
YoY Change -17.13%
Total Long-Term Liabilities $13.73M $14.44M $16.57M
YoY Change -17.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.466M $54.06M $1.179M
Total Long-Term Liabilities $13.73M $14.44M $16.57M
Total Liabilities $20.20M $255.4M $17.75M
YoY Change 13.8% 1030.93%
SHAREHOLDERS EQUITY
Retained Earnings -$20.14M -$18.23M
YoY Change -14.96%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$20.13M -$155.8M -$16.79M
YoY Change
Total Liabilities & Shareholders Equity $121.4M $104.0M $231.0M
YoY Change -47.44% -55.01%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.107M $2.510M $4.642M
YoY Change -123.85%
Depreciation, Depletion And Amortization $2.796M $507.0K $63.00K
YoY Change 4338.1%
Cash From Operating Activities -$85.56K -$175.7K -$224.4K
YoY Change -61.87%
INVESTING ACTIVITIES
Capital Expenditures -$2.133M -$631.0K -$27.00K
YoY Change 7800.0%
Acquisitions
YoY Change
Other Investing Activities $108.7M $0.00 $13.37K
YoY Change 812667.54%
Cash From Investing Activities $108.7M $0.00 $13.37K
YoY Change 812789.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -108.7M 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -85.56K -175.7K -224.4K
Cash From Investing Activities 108.7M 0.000 13.37K
Cash From Financing Activities -108.7M 0.000 0.000
Net Change In Cash -138.3K -175.7K -211.0K
YoY Change -34.45%
FREE CASH FLOW
Cash From Operating Activities -$85.56K -$175.7K -$224.4K
Capital Expenditures -$2.133M -$631.0K -$27.00K
Free Cash Flow $2.047M $455.3K -$197.4K
YoY Change -1137.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001802450
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 lcapu Redemption Period Upon Closure
RedemptionPeriodUponClosure
P10D
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39445
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Lionheart Acquisition Corporation II
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4117825
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4218 NE 2nd Avenue
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
CY2022Q1 dei City Area Code
CityAreaCode
305
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
573-3900
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
true
CY2022Q1 us-gaap Cash
Cash
39058
CY2021Q4 us-gaap Cash
Cash
177386
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8611
CY2022Q1 us-gaap Assets Current
AssetsCurrent
39058
CY2021Q4 us-gaap Assets Current
AssetsCurrent
185997
CY2022Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
121354431
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230013074
CY2022Q1 us-gaap Assets
Assets
121393489
CY2021Q4 us-gaap Assets
Assets
230199071
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18224716
CY2022Q1 lcapu Remeasurement Of Temporary Equity To Redemption Value Adjustment
RemeasurementOfTemporaryEquityToRedemptionValueAdjustment
802772
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1107168
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-20134656
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21431351
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4641710
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5715912
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3985037
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
750000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6465912
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3985037
CY2022Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
5679250
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
6388750
CY2022Q1 lcapu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8050000
CY2021Q4 lcapu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8050000
CY2022Q1 us-gaap Liabilities
Liabilities
20195162
CY2021Q4 us-gaap Liabilities
Liabilities
18423787
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
121332983
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
230000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20135296
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18225356
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-20134656
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18224716
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
121393489
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
230199071
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1825042
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
209938
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1825042
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-209938
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8374
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3398
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-709500
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4848250
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
717874
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4851648
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1107168
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4641710
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-16789641
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1107168
CY2021Q1 us-gaap Profit Loss
ProfitLoss
4641710
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-709500
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4848250
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8374
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3398
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8611
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
24012
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1730875
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9552
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-85556
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-224398
CY2022Q1 lcapu Payments For Extension Contribution Into Trust Account
PaymentsForExtensionContributionIntoTrustAccount
802772
CY2022Q1 lcapu Proceeds From Investment Of Cash In Trust Account
ProceedsFromInvestmentOfCashInTrustAccount
109469789
CY2021Q1 us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
-13368
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
108667017
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13368
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
750000
CY2022Q1 lcapu Redemption Of Class Common Stock Subject To Possible Redemption
RedemptionOfClassCommonStockSubjectToPossibleRedemption
109469789
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-108719789
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-138328
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-211030
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177386
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1017137
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39058
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
806107
CY2021Q1 lcapu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
5450
CY2022Q1 lcapu Remeasurement Of Class Common Stock To Redemption Value
RemeasurementOfClassCommonStockToRedemptionValue
802772
CY2022Q1 lcapu Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
CY2022Q1 lcapu Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
CY2022Q1 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
10946369
CY2022Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
109469789
CY2022Q1 lcapu Debt Instrument Held To Trust Account Par Value
DebtInstrumentHeldToTrustAccountParValue
0.0333
CY2022Q1 lcapu Payments For Extension Contribution Into Trust Account
PaymentsForExtensionContributionIntoTrustAccount
802772
CY2022Q1 lcapu Dissolution Expenses Payable
DissolutionExpensesPayable
100000
CY2022Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
39058
CY2022Q1 lcapu Working Capital Deficit Net
WorkingCapitalDeficitNet
-6392038
CY2021Q4 lcapu Condition For Require Each Party To Pay Filling Fee Percentage
ConditionForRequireEachPartyToPayFillingFeePercentage
50
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.</p>
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Out of Period Adjustments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company notes that approximately $96,800 of adjustments related to the year ended December 31, 2021 have been corrected and recorded within the three months ended March 31, 2022. The Company has not restated or revised its previous balances for the year ended December 31, 2021. The Company will continue to evaluate the impacts of the out of period adjustments within the fiscal year 2022 reported balances.</p>
CY2022Q1 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
96800
CY2022Q1 lcapu Debt Instrument Held To Trust Account Par Value
DebtInstrumentHeldToTrustAccountParValue
0.0333
CY2022Q1 lcapu Payments For Extension Contribution Into Trust Account
PaymentsForExtensionContributionIntoTrustAccount
802772
CY2020Q3 lcapu Related Party Transaction General And Administrative Services Expense Per Month
RelatedPartyTransactionGeneralAndAdministrativeServicesExpensePerMonth
15000
CY2022Q1 lcapu Proceeds Held In Trust Account To Repay Working Capital Loans
ProceedsHeldInTrustAccountToRepayWorkingCapitalLoans
0
CY2022Q1 lcapu Related Party Transaction Price Per Unit Upon Consummation Of Business Combination
RelatedPartyTransactionPricePerUnitUponConsummationOfBusinessCombination
10.00
CY2020Q3 lcapu Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 lcapu Convertible Stock Conversion Ratio
ConvertibleStockConversionRatio
1
CY2022Q1 lcapu Percentage Of Common Stock Outstanding For Conversion Basis
PercentageOfCommonStockOutstandingForConversionBasis
0.20
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
3500000

Files In Submission

Name View Source Status
0001410578-22-001799-index-headers.html Edgar Link pending
0001410578-22-001799-index.html Edgar Link pending
0001410578-22-001799.txt Edgar Link pending
0001410578-22-001799-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lcapu-20220331.xsd Edgar Link pending
lcapu-20220331x10q.htm Edgar Link pending
lcapu-20220331x10q_htm.xml Edgar Link completed
lcapu-20220331xex31d1.htm Edgar Link pending
lcapu-20220331xex31d2.htm Edgar Link pending
lcapu-20220331xex32d1.htm Edgar Link pending
lcapu-20220331xex32d2.htm Edgar Link pending
lcapu-20220331_cal.xml Edgar Link unprocessable
lcapu-20220331_def.xml Edgar Link unprocessable
lcapu-20220331_lab.xml Edgar Link unprocessable
lcapu-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending